NUS Nu Skin Enterprises Inc

Price (delayed)

$52.01

Market cap

$2.59B

P/E Ratio

11.48

Dividend/share

$1.52

EPS

$4.53

Enterprise value

$2.79B

Founded more than 35 years ago, Nu Skin Enterprises, Inc. empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its ...

Highlights
The price to earnings (P/E) is 40% less than the 5-year quarterly average of 19.2 and 5% less than the last 4 quarters average of 12.1
The gross profit has grown by 14% YoY
The company's EPS has surged by 51% YoY but it fell by 2.4% QoQ
The net income rose by 46% year-on-year but it has declined by 2.8% since the previous quarter
The quick ratio is down by 31% year-on-year and by 10% since the previous quarter

Key stats

What are the main financial stats of NUS
Market
Shares outstanding
49.82M
Market cap
$2.59B
Enterprise value
$2.79B
Valuations
Price to earnings (P/E)
11.48
Price to book (P/B)
2.78
Price to sales (P/S)
0.94
EV/EBIT
9.14
EV/EBITDA
6.42
EV/Sales
1.01
Earnings
Revenue
$2.77B
EBIT
$305.46M
EBITDA
$434.81M
Free cash flow
$61.37M
Per share
EPS
$4.53
Free cash flow per share
$1.22
Book value per share
$18.68
Revenue per share
$55.3
TBVPS
$33.34
Balance sheet
Total assets
$1.97B
Total liabilities
$1.04B
Debt
$484.3M
Equity
$936.48M
Working capital
$350.28M
Liquidity
Debt to equity
0.52
Current ratio
1.65
Quick ratio
0.65
Net debt/EBITDA
0.46
Margins
EBITDA margin
15.7%
Gross margin
74.9%
Net margin
8.3%
Operating margin
10.9%
Efficiency
Return on assets
11.6%
Return on equity
25.4%
Return on invested capital
24.1%
Return on capital employed
21.3%
Return on sales
11%
Dividend
Dividend yield
2.92%
DPS
$1.52
Payout ratio
33.6%

NUS stock price

How has the Nu Skin Enterprises stock price performed over time
Intraday
-1.55%
1 week
-1.27%
1 month
4.99%
1 year
-9.86%
YTD
2.48%
QTD
2.48%

Financial performance

How have Nu Skin Enterprises's revenue and profit performed over time
Revenue
$2.77B
Gross profit
$2.07B
Operating income
$302.37M
Net income
$229.96M
Gross margin
74.9%
Net margin
8.3%
The net income rose by 46% year-on-year but it has declined by 2.8% since the previous quarter
The company's operating income rose by 35% YoY but it fell by 2.8% QoQ
The net margin has increased by 28% year-on-year
Nu Skin Enterprises's operating margin has increased by 18% YoY

Growth

What is Nu Skin Enterprises's growth rate over time

Valuation

What is Nu Skin Enterprises stock price valuation
P/E
11.48
P/B
2.78
P/S
0.94
EV/EBIT
9.14
EV/EBITDA
6.42
EV/Sales
1.01
The company's EPS has surged by 51% YoY but it fell by 2.4% QoQ
The price to earnings (P/E) is 40% less than the 5-year quarterly average of 19.2 and 5% less than the last 4 quarters average of 12.1
The P/B is 23% below the 5-year quarterly average of 3.6 and 4.1% below the last 4 quarters average of 2.9
NUS's equity is up by 13% year-on-year and by 2% since the previous quarter
The price to sales (P/S) is 22% lower than the 5-year quarterly average of 1.2 and 6% lower than the last 4 quarters average of 1.0
NUS's revenue is up by 15% YoY but it is down by 2.2% from the previous quarter

Efficiency

How efficient is Nu Skin Enterprises business performance
The return on invested capital rose by 34% year-on-year but it has declined by 5% since the previous quarter
The company's return on equity rose by 32% YoY but it fell by 6% QoQ
The ROA is up by 30% YoY but it is down by 4.9% from the previous quarter
The company's return on sales rose by 22% YoY

Dividends

What is NUS's dividend history
DPS
$1.52
Dividend yield
2.92%
Payout ratio
33.6%
Recent dividends

Financial health

How did Nu Skin Enterprises financials performed over time
The total assets is 90% more than the total liabilities
The quick ratio is down by 31% year-on-year and by 10% since the previous quarter
The total assets has grown by 9% YoY but it has contracted by 3.7% from the previous quarter
The debt is 48% smaller than the equity
NUS's equity is up by 13% year-on-year and by 2% since the previous quarter
The debt to equity has declined by 12% since the previous quarter and by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.